Myxobacteria have been regarded as a promissing source of secondary metabolites and more than 80 novel basic structures and more than 400 variants of these compounds have been isolated from this group*~3). Recently, we succeeded, for the first time, in isolating myxobacteria]
strains from marine environments and proved them to be adapted to marine environments4Î n search for the bioactive agents from marine myxobacteria, we discovered the novel antifungal polyunsaturated antibiotic with a /?-methoxyacrylate moiety and named it haliangicin5) ( Fig. 1 ). This paper describes the fermentation and biological properties of haliangicin. The isolation and structural elucidation of haliangin will be reported in the accompany paper6).
Materials and Methods

Microorganisms
Myxobacterial strain AJ-13395 was isolated from a seaweed sample collected at a sandy beach in the Miura Peninsula, Kanagawa, Japan. From phylogenetic and physiological studies, this strain was assigned as a new genus in the myxobacterial clade4), arid was tentatively named as Haliangium luteum. The detailed description of the strain will be reported elsewhere.
Fermentati on
Myxobacterial strain was cultivated at 28°C on the Vy2-ASWmedium (seed medium)4). The Vy2-ASWmedium CaCl2-2H2O 1 g, KC1 0.5g, NaHCO3 0.16g, H3BO3 0.02g, KBr 0.08g, SrCl2 0.03g, glycerophosphate-2Na 0.01 g, trace element solution4) 1 ml, (pH 7.0 by KOH). Adsorber resin SP207 (1%, Mitsubishi chemical Co.) was added to production mediumon day 4 to enhance the productivity. Fermentation was conducted on a rotary shaker (180rpm) at 28°C for 17 days.
Detection Methods
The productivity of haliangicin was measured by HPLC of an acetone extract of bacterial cells and adsorber resin.
Separation was performed using a Capcel pak ODS column (250X4.6mm) followed by elution with 70% acetonitrile solution. Detection was by UVabsorption at 254nm. Retention time ofhaliangicin was 16.5 minute.
The extraction and purification of haliangicin was also followed by monitoring the antifungal activity against Aspergillus niger (AJ 117374) using the paper disc diffusion method.
In Vitro Antimicrobial Assay 
Results
Fermentati on
The typical time course of the haliangicin production is shown in Fig.2 . Since the strain grew in clumps, pH was used as a growth parameter instead of the measurements of optical densities. Production started at about day 7 and reached a maximumat day 12. The productivity of haliangicin was greatly enhanced by the addition of 2% absorber resin SP207. Since the bacterium was originally isolated from marine environment, the effect of salt concentration on antibiotic production was investigated. As shown in Fig. 3 , the bacterium required NaCl for the haliangicin production with optimal around 2-3%, which is roughly equivalent to the level in sea water.
Biological Properties
The antimicrobial activities of haliangicin is shownin Since several /3-methoxyacrylate type compounds are known to inhibit respiration of fungi and other eukaryotes8~12), we investigated the effect of haliangicin on the electron transport chains of mitochondria. Fig. 4 shows the inhibition of NADH oxidation by beef heart submitochondrial membranes with haliangicin along with myxothiazol A, cystothiazole A (as positive references) and amphotericin B (as negative control). Inhibition value of haliangicin was markedly higher than those of myxothiazol transport chain, the difference spectra of mitochondrial membranes (NADH-reduced minus air oxidized) were measured (Fig. 5) . In the presence of haliangicin, only one peak (at 564 nm corresponding to a-band of cytochrome b) was observed indicating that cytochrome b of complex III was reduced whereas cytochrome aa3 (a-band at 608 nm) and cytochrome c+cl (a-band at 553 nm) remained in the oxidized state. These results suggest that haliangicin blocked the electron flow within cytochrome b-cl segment of the respiratory chain.
Haliangicin was found to be toxic to the animal cell line; the cytotoxicity (IC50) for mouse P388 cell was 0.21 jam. Haliangicin is also a memberof this class of compounds with /3-methoxyacrylate moiety, which appear to confer its antifungal activity of haliangicin. This notion was supported by the fact that haliangicin specifically inhibits the electron transport within the complexIII of respiratory chain, like other /3-methoxyacrylate inhibitors such as myxothiazols7), melithiazolsH) and cystothiazoles (our unpublished data). It is of special interest that haliangicin has the most potent in vitro activities among those substances with the IC50 of 2.5 nM (=0.94 ng/ml), although the reason for that remains to be elucidated.
